Success Metrics

Clinical Success Rate
88.3%

Based on 310 completed trials

Completion Rate
88%(310/351)
Active Trials
78(13%)
Results Posted
16%(49 trials)
Terminated
41(7%)

Phase Distribution

Ph not_applicable
297
49%
Ph phase_3
8
1%
Ph early_phase_1
6
1%
Ph phase_1
10
2%
Ph phase_2
12
2%
Ph phase_4
24
4%

Phase Distribution

16

Early Stage

12

Mid Stage

32

Late Stage

Phase Distribution357 total trials
Early Phase 1First-in-human
6(1.7%)
Phase 1Safety & dosage
10(2.8%)
Phase 2Efficacy & side effects
12(3.4%)
Phase 3Large-scale testing
8(2.2%)
Phase 4Post-market surveillance
24(6.7%)
N/ANon-phased studies
297(83.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.4%

310 of 363 finished

Non-Completion Rate

14.6%

53 ended early

Currently Active

78

trials recruiting

Total Trials

610

all time

Status Distribution
Active(110)
Completed(310)
Terminated(53)
Other(137)

Detailed Status

Completed310
unknown135
Recruiting60
Terminated41
Not yet recruiting29
Active, not recruiting18

Development Timeline

Analytics

Development Status

Total Trials
610
Active
78
Success Rate
88.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (1.7%)
Phase 110 (2.8%)
Phase 212 (3.4%)
Phase 38 (2.2%)
Phase 424 (6.7%)
N/A297 (83.2%)

Trials by Status

withdrawn122%
suspended20%
active_not_recruiting183%
not_yet_recruiting295%
terminated417%
recruiting6010%
enrolling_by_invitation30%
completed31051%
unknown13522%

Recent Activity

Clinical Trials (610)

Showing 20 of 610 trialsScroll for more
NCT02382601

Longitudinal Study of Intra-Uterine Growth Restriction

Recruiting
NCT06014749Phase 4

Serratus Intercostal Block Versus Epidural/Port Infiltration Analgesia in Eventration: Prospective Non Inferiority Study

Completed
NCT06876714Phase 3

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Recruiting
NCT06878547

VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients

Recruiting
NCT05726201

(POCUS) As an Early Screening Tool for Diagnosing Skull Fractures in Children

Completed
NCT07467382

GOAT (Gait Observation of Achilles Tendon)

Not Yet Recruiting
NCT07336173

Uterine Artery Doppler Indices and Uterocervical Angle Measurment in Prediction of Preterm Labor

Recruiting
NCT06140615Not Applicable

Lung Ultrasound - Prospective Study

Completed
NCT07586592Not Applicable

Comparison of Age-Based Formula and Ultrasound-Guided Subglottic Diameter Measurement for Endotracheal Tube Sizing

Recruiting
NCT05922085Not Applicable

Use of Ultrasound for Early Identification of Patients at Risk of Swallowing Disorders Acquired in the ICU

Recruiting
NCT06762288Not Applicable

Transversus Abdominis Plan (TAP) Block for Transcatheter Aortic Valve Implantation (TAVI)

Completed
NCT07575633Not Applicable

Ultrasound Versus Virtual Reality on Temporomandibular Disorder

Not Yet Recruiting
NCT06576128Not Applicable

Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions

Recruiting
NCT04178018Not Applicable

Transvaginal Ultrasound and Photoacoustic Imaging of Ovary

Terminated
NCT07572591Not Applicable

Ultrasound for Peripheral Nerve Modulation

Not Yet Recruiting
NCT02176967Phase 3

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Active Not Recruiting
NCT06345547

Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)

Recruiting
NCT04837833Not Applicable

An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma

Active Not Recruiting
NCT04126161Not Applicable

HIP: Hip Imaging Protocol

Completed
NCT04743362

A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions

Recruiting

Drug Details

Intervention Type
RADIATION
Total Trials
610